Orgenesis Inc. logo

Orgenesis Inc.

NASDAQ:ORGS

Overview | Financials
Company Name Orgenesis Inc.
Symbol ORGS
Currency USD
Price 0.51
Market Cap 17,533,953
Dividend Yield 0%
52-week-range 0.25 - 1.5
Industry Biotechnology
Sector Healthcare
CEO Ms. Vered Caplan M.Sc.
Website https://www.orgenesis.com

An error occurred while fetching data.

About Orgenesis Inc.

Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies,

Related Stocks

Akebia Therapeutics, Inc. logo

Akebia Therapeutics, Inc.

AKBA

1.13 USD

DiaMedica Therapeutics Inc. logo

DiaMedica Therapeutics Inc.

DMAC

3.04 USD

InflaRx N.V. logo

InflaRx N.V.

IFRX

1.52 USD

Novo Integrated Sciences, Inc. logo

Novo Integrated Sciences, Inc.

NVOS

0.477 USD

Streamline Health Solutions, Inc. logo

Streamline Health Solutions, Inc.

STRM

0.32 USD

Rain Therapeutics Inc. logo

Rain Therapeutics Inc.

RAIN

1.21 USD

MediWound Ltd. logo

MediWound Ltd.

MDWD

17.18 USD

Financials

Numbers are in millions USD

Numbers are in millions USD